共 34 条
[1]
Duntas L.H., Thyroid disease and lipids, Thyroid, 12, pp. 287-293, (2002)
[2]
Polikar R., Burger A.G., Scherrer U., Nicod P., The thyroid and the heart, Circulation, 87, 5, pp. 1435-1441, (1993)
[3]
Braverman L.E., Ingbar S.H., Sterling K., Conversion of T4 to T3 in athyreotic subjects, J Clin Invest., 49, pp. 855-864, (1970)
[4]
Antonio C., Salvatore D., Gereben B., Berry M.J., Larsen P.R., Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases, Endocr Rev., 23, 1, pp. 38-89, (2002)
[5]
Collins F.S., Brooks L.D., Chakravarti A., A DNA polymorphism discovery resource for research on human genetic variabtion, Genome Res., 8, pp. 1229-1231, (1998)
[6]
Brookes A.J., The essence of SNP’s, Gene, 234, pp. 177-186, (1999)
[7]
Dora A.J., Machado W.E., Rheinheimer J., Crispim D., Maia A.L., Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes: case–control study and meta-analysis, Eur J Endocrinol., 163, pp. 427-434, (2010)
[8]
Canani L.H., Capp C., Dora J.M., Meyer E.L., Wagner M.S., Harney J.W., Et al., The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus, J Clin Endocrinol Metab., 90, pp. 3472-3478, (2005)
[9]
Meulenbelt I., Min J.L., Bos S., Riyazi N., Houwing-Duistermaat J.J., Van Der Wijk H.J., Et al., Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis, Hum Mol Genet., 17, pp. 1867-1875, (2008)
[10]
Gumieniak O., Perlstein T.S., Williams J.S., Hopkins P.N., Brown N.J., Raby B.A., Et al., Ala92 type 2 deiodinase allele increases risk for the development of hypertension, Hypertension, 49, pp. 461-466, (2007)